One of the highlights of Eli Lilly's third-quarter results ... with fewer than 10% switching from Trulicity, said Lilly's chief financial officer Anat Ashkenazi on the call. Now, Lilly's focus ...

Eli Lilly has called on financial regulators ... The issue was also alluded to by Lilly’s chief financial officer, Anat Ashkenazi, on the company’s fourth-quarter results call yesterday ...

It is also a huge week for biotech and pharmaceutical earnings, with Amgen, Pfizer, Eli Lilly and Neurocrine ... Alphabet's new chief financial officer, Anat Ashkenazi, is expected to lay out ...

Google CFO Anat Ashkenazi discusses team consolidation efforts aimed at reducing costs and speeding up product delivery.

Google's team consolidation strategy is yielding positive results, with CFO Anat Ashkenazi reporting cost reductions and increased operational speed during the Q1 earnings call. The company ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow before market hours. Here’s what to look for. Eli Lilly met analysts’ revenue expectations last quarter ...

The last couple of quarters have been very favorable for Eli Lilly and Company (NYSE:LLY) and its position in the obesity and adjacent markets. The main competitor Novo Nordisk A/S (NVO ...

Pharmaceutical giant Eli Lilly and Co. sued Willow Health Services and three other companies in federal court in New Jersey and California, accusing them of selling unapproved compounded ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as ...

Eli Lilly is scheduled to report its quarterly results on May 1. The company may report its Q1 results in line with peers. Don't face extreme market conditions unprepared. Get the professional ...